Rolta India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 11:04 pm

Competitors of Rolta India Ltd

All Competitor Stocks of Rolta India Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:25 am

Below is a detailed analysis of the quarterly data for Rolta India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Expenses, as of Jun 2025, the value is 1.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2025) to 1.83 Cr., marking a decrease of 0.17 Cr..
• For Operating Profit, as of Jun 2025, the value is -1.83 Cr.. The value appears strong and on an upward trend. It has increased from -2.00 Cr. (Mar 2025) to -1.83 Cr., marking an increase of 0.17 Cr..
• For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Other Income, as of Jun 2025, the value is 2.38 Cr.. The value appears to be declining and may need further review. It has decreased from 3.86 Cr. (Mar 2025) to 2.38 Cr., marking a decrease of 1.48 Cr..
• For Interest, as of Jun 2025, the value is 0.18 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.18 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.28 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 0.28 Cr..
• For Profit before tax, as of Jun 2025, the value is -6.63 Cr.. The value appears to be declining and may need further review. It has decreased from -5.60 Cr. (Mar 2025) to -6.63 Cr., marking a decrease of 1.03 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -6.63 Cr.. The value appears to be declining and may need further review. It has decreased from -5.60 Cr. (Mar 2025) to -6.63 Cr., marking a decrease of 1.03 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.40. The value appears to be declining and may need further review. It has decreased from -0.34 (Mar 2025) to -0.40, marking a decrease of 0.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:10 pm

Growth

Last Updated: September 5, 2025, 1:10 pm

Balance Sheet

Last Updated: June 16, 2025, 11:26 am

Below is a detailed analysis of the balance sheet data for Rolta India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 166.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 166.00 Cr..
• For Reserves, as of Mar 2025, the value is -10,482.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -10,321.00 Cr. (Mar 2024) to -10,482.00 Cr., marking a decline of 161.00 Cr..
• For Borrowings, as of Mar 2025, the value is 10,846.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 10,747.00 Cr. (Mar 2024) to 10,846.00 Cr., marking an increase of 99.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,209.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,153.00 Cr. (Mar 2024) to 2,209.00 Cr., marking an increase of 56.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,738.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,745.00 Cr. (Mar 2024) to 2,738.00 Cr., marking a decrease of 7.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,250.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,279.00 Cr. (Mar 2024) to 1,250.00 Cr., marking a decrease of 29.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,489.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,466.00 Cr. (Mar 2024) to 1,489.00 Cr., marking an increase of 23.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,738.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,745.00 Cr. (Mar 2024) to 2,738.00 Cr., marking a decrease of 7.00 Cr..

However, the Borrowings (10,846.00 Cr.) are higher than the Reserves (-10,482.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Rolta India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -1.56. This value is below the healthy minimum of 5. It has increased from -61.41 (Mar 24) to -1.56, marking an increase of 59.85.
• For Diluted EPS (Rs.), as of Mar 25, the value is -1.56. This value is below the healthy minimum of 5. It has increased from -61.41 (Mar 24) to -1.56, marking an increase of 59.85.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 3. It has increased from -59.44 (Mar 24) to 0.21, marking an increase of 59.65.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -621.89. It has decreased from -616.67 (Mar 24) to -621.89, marking a decrease of 5.22.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -621.89. It has decreased from -612.17 (Mar 24) to -621.89, marking a decrease of 9.72.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 2. It has decreased from 0.56 (Mar 24) to 0.25, marking a decrease of 0.31.
• For PBIT / Share (Rs.), as of Mar 25, the value is -1.53. This value is below the healthy minimum of 0. It has decreased from -1.42 (Mar 24) to -1.53, marking a decrease of 0.11.
• For PBT / Share (Rs.), as of Mar 25, the value is -1.57. This value is below the healthy minimum of 0. It has decreased from -1.48 (Mar 24) to -1.57, marking a decrease of 0.09.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -1.57. This value is below the healthy minimum of 2. It has increased from -61.41 (Mar 24) to -1.57, marking an increase of 59.84.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.57. This value is below the healthy minimum of 2. It has increased from -61.41 (Mar 24) to -1.57, marking an increase of 59.84.
• For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 8. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 10. It has increased from 0.23 (Mar 24) to 0.24, marking an increase of 0.01.
• For Return On Assets (%), as of Mar 25, the value is -0.95. This value is below the healthy minimum of 5. It has increased from -37.11 (Mar 24) to -0.95, marking an increase of 36.16.
• For Total Debt / Equity (X), as of Mar 25, the value is -1.05. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded -1.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Current Ratio (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.34. This value is within the healthy range. It has decreased from 9.23 (Mar 24) to 6.34, marking a decrease of 2.89.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -37.91. This value is below the healthy minimum of 3. It has increased from -1,007.71 (Mar 24) to -37.91, marking an increase of 969.80.
• For Enterprise Value (Cr.), as of Mar 25, the value is 10,650.41. It has increased from 10,607.84 (Mar 24) to 10,650.41, marking an increase of 42.57.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For EV / EBITDA (X), as of Mar 25, the value is 2,505.98. This value exceeds the healthy maximum of 15. It has increased from 1,138.18 (Mar 24) to 2,505.98, marking an increase of 1,367.80.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has increased from -0.01 (Mar 24) to 0.00, marking an increase of 0.01.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For EarningsYield, as of Mar 25, the value is -0.77. This value is below the healthy minimum of 5. It has increased from -12.74 (Mar 24) to -0.77, marking an increase of 11.97.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness